Massachusetts Financial Services’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
Other funds holding ACOR
Massachusetts Financial Services's ACOR Position: Q2 2020 in Review
Massachusetts Financial Services sold out of Acorda Therapeutics (ACOR) in Q2 2020, closing a stake of 2,295 shares — an estimated $257K sold.
Massachusetts Financial Services first reported a position in ACOR in Q2 2013 and held it in 19 quarters. The position peaked at $1.75M in Q2 2019. 79 funds tracked by Wall St. Rank hold ACOR as of Q2 2020.
- Massachusetts Financial Services reported no remaining Acorda Therapeutics position as of Q2 2020 after selling out during the quarter.
- Massachusetts Financial Services sold 2,295 Acorda Therapeutics shares in Q2 2020, an estimated $257K.
- Massachusetts Financial Services first reported a position in Acorda Therapeutics in Q2 2013 and held it in 19 quarters.
- Massachusetts Financial Services's Acorda Therapeutics position peaked at $1.75M in Q2 2019.
- 79 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2020.
Based on Massachusetts Financial Services's 13F filing for Q2 2020, filed 11 Aug 2020.